• November 16, 2018

ROTH Capital Partners Announces the Addition of Jerry Isaacson, Ph.D. to its Healthcare Research Team - Odessa American: Business

e-Edition Subscribe

ROTH Capital Partners Announces the Addition of Jerry Isaacson, Ph.D. to its Healthcare Research Team

Print
Font Size:
Default font size
Larger font size

Posted: Monday, November 5, 2018 9:57 am | Updated: 10:15 am, Mon Nov 5, 2018.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Nov 5, 2018--ROTH Capital Partners (“ROTH”), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that Jerry Isaacson, Ph.D. has joined the firm’s healthcare research team.

Dr. Isaacson is a Managing Director and Senior Research Analyst covering biotechnology and emerging therapeutics. Jerry has a broad range of experience covering companies in many different disease areas as well as medical devices and diagnostics. He is particularly focused on anti-infectives, gene therapy, and oncology. Prior to joining ROTH he spent seven years leading the research group of LifeSci Capital, where he built the research team from the ground up and initiated coverage on more than 100 companies. Prior to joining LifeSci Capital, Dr. Isaacson was an editor at the Medical Technology Stock Letter primarily covering oncology and diabetes companies. His previous experience includes work in the biotechnology industry, where he served in various roles ranging from analytical and medicinal chemistry to corporate communications and writing patents. Jerry earned his Ph.D. in organic chemistry at the University of California at San Diego conducting total synthesis of natural products and received his Bachelor of Arts degree in chemistry from Harvard University.

Jeff Martin, Director of Research, commented, “Building on our continued success in identifying compelling investment opportunities in the healthcare sector, I’m pleased to welcome Dr. Isaacson to our thought-leading biotechnology research team. His strong academic background in organic chemistry combined with his extensive experience in covering biotechnology companies will undoubtedly serve our clients well.”

Dr. Isaacson commented, “I am very excited to join the strong biotechnology team at ROTH, which has distinguished itself with industry leading coverage in NASH, oncology, and immunology. The recent emergence of new treatment modalities as well as genomic and diagnostic tools makes this a very exciting time in the biotechnology arena for patients, physicians, drug developers, and investors. I look forward to working with the rest of the ROTH biotechnology team to continue to provide high quality research with a focus on uncovering unrecognized value in future industry leaders and game changing therapeutics.”

“We are excited to have Jerry join our healthcare research team,” said Byron Roth, CEO of ROTH Capital Partners. “His addition further demonstrates our unwavering commitment to the life sciences sector. I’m confident that Jerry’s expertise in biotechnology will enhance our ability to continue to build upon our over ten-year track record of success in assisting both companies and investors in the healthcare sector.”

About Roth Capital Partners, LLC:

ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access.

Headquartered in Newport Beach, Calif., ROTH is privately-held and owned by its employees, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181105005658/en/

CONTACT: Investor and Media Contact:

ROTH Capital Partners

Isabel Mattson-Pain, Director of Marketing

Imattson-pain@roth.com

949-720-7117

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PROFESSIONAL SERVICES BANKING COMMUNICATIONS PUBLIC RELATIONS/INVESTOR RELATIONS

SOURCE: ROTH Capital Partners

Copyright Business Wire 2018.

PUB: 11/05/2018 10:57 AM/DISC: 11/05/2018 10:57 AM

http://www.businesswire.com/news/home/20181105005658/en

© 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Clear
59°
Humidity: 24%
Winds: S at 6mph
Feels Like: 58°

Your Extended Forecast

Tomorrow

weather
High N/A°/Low 37°
Mainly clear. Lows overnight in the upper 30s.

saturday

weather
High 65°/Low 33°
A few clouds. Highs in the mid 60s and lows in the low 30s.

sunday

weather
High 49°/Low 33°
Mostly cloudy. Highs in the upper 40s and lows in the low 30s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7670 to sign up today.